Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

Summary

The proposed project will have two separate cohorts. The first will be to perform a more in-depth qualitative assessment of the barriers and facilitators for treatment compliance for non-muscle invasive bladder cancer. The second arm will be to create and test a BCG at home program. Participants in the second cohort will be enrolled in a conversational agent to measure patient symptoms and quality of life and improve self-efficacy.

Eligibility

Inclusion Criteria:

Inclusion criteria for patients in Cohort 1

* Age 18 years or older;
* completed intravesical treatment for non-muscle invasive bladder cancer within the past year Cohort 1 inclusion criteria for key stakeholders
* Age 18 years or older;
* experience with the delivery of BCG delivery for more than 2 years

Cohort 2 inclusion criteria

* Age 18 years or older;
* diagnosed with non-muscle invasive bladder cancer and prescribed BCG for initial therapy

Exclusion Criteria:

Cohort 1 exclusion criteria

• inability to provide informed consent

Cohort 2 exclusion criteria

* inability to provide informed consent
* inability to undergo catheterization (i.e. - history of urethral stricture)
* inability to receive BCG therapy (i.e. - previous reaction with BCG)
* no access to mobile phone
* inability to respond to written conversations in English

Conditions2

Locations1 site

Browse More Trials